Articles tagged "Kidney transplantation"

2016 American Transplant Congress
Long Term Follow Up of Kidney Donors with Asymptomatic Renal Stones.
D. Serur,¹ M. Charlton,² K. Juluru,³ G. Salama,³ E. LoCastro,³ G. Bretzlaff,² C. Hartono.¹
¹Nephrology/Rogosin, New York Presbyterian Weill Cornell, New York, NY; ²Kidney and Pancreas Transplantation, New York Presbyterian Weill Cornell, New York, NY; ³Radiology, New York Presbyterian Weill Cornell, New York, NY.
BACKGROUND:Kidney stones are often found incidentally in potential renal donors and there is a concern that they may become symptomatic and cause damage in the…
2016 American Transplant Congress
Natural Language Processing Methods Allow Reliable Extraction of Banff Scores and Grades.
K. Reilly,¹ L. Lenert,¹ H. Anwar,² J. Thompson,¹ D. Taber,¹ P. Mauldin,¹ T. Srinivas.¹
¹MUSC, Charleston; ²IBM, NY.
Objective: National Data are sparse with regard to pathology of rejection. Incorporating biopsy pathology grades and lesion scores into analyses requires manual extraction and entry…
2016 American Transplant Congress
Evaluating Delayed Graft Function After Kidney Transplantation as a Potential Surrogate Outcome.
S. Cramm, X. Luo, A. Massie, D. Segev.
Department of Surgery, Johns Hopkins, Baltimore, MD.
Background: Recent work demonstrates significant inter-center heterogeneity in delayed graft function (DGF) rates after kidney transplantation, calling into question the value of a metric based…
2016 American Transplant Congress
The Effect of Everolimus and Tacrolimus Exposure Levels on Renal Histology Parameters 6 Months Post-Transplantation.
S. Yilmaz,¹ D. Shaffer,² Y. Qazi,³ K. McCague,⁴ D. Patel,⁴ V. Peddi,⁵ F. Vincenti.⁶
¹University of Calgary, Calgary, Canada; ²Vanderbilt University, Nashville; ³University of Southern California, Los Angeles; ⁴Novartis Pharmaceuticals Corporation, East Hanover; ⁵California Pacific Medical Center, San Francisco; ⁶University of California San Francisco, San Francisco.
We examined renal histology scores in patients with different exposure levels of everolimus (EVR) and tacrolimus (TAC) over 6 months.Renal transplant patients (N=613) were randomized…
2016 American Transplant Congress
Incidence, Risk Factors, and Outcomes of Delayed Graft Function in Deceased Donor Kidney Transplantation in a Brazilian Center.
A. Ribeiro,¹ M. Helfer,² O. Costa,² A. Viccari,¹ R. Manfro.^1,2
¹Division of Nephrology, Renal Transplant Unit, Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil; ²School of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Background. A high incidence of delayed graft function (DGF), after deceased donor kidney transplantation, occurs in Brazil and the reasons for such finding have not…
2016 American Transplant Congress
Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation – Prospective Trial of Once-Daily vs. Twice-Daily Tac – 5 Years Second Report.
T. Tsuchiya, H. Ishida, T. Nozaki, H. Shirakawa, T. Shimizu, K. Omoto, M. Okumi, K. Tanabe.
Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.
Background; Previously, we reported a comparison of the safety and pharmacokinetics between a prolonged-release formulation of Tacrolimus (Tac-QD) and twice-daily tacrolimus (Tac-BD) in the early…
2016 American Transplant Congress
Impediments to Timely Listing for HIV+ Patients Being Evaluated for Kidney Transplantation.
D. Lee,¹ A. Aldea,¹ M. Harhay,² S. Akshay,² G. Malat,³ N. Law,¹ S. DeBellis,² T. Bias,¹ S. Boyle,² K. Ranganna,² A. Doyle.²
¹Division of Infectious Diseases and HIV Medicine, Drexel University, Philadelphia; ²Division of Nephrology, Drexel University, Philadelphia; ³Department of Surgery, Drexel University, Philadelphia.
Introduction:HIV+ individuals can be transplanted safely and effectively but face additional barriers in evaluation and listing.MethodsWe performed a single center chart review of all HIV+…
2016 American Transplant Congress
A Weighted Approach to Composite Efficacy Analysis in Kidney Transplantation.
B. Kaplan, K. MaCague, D. Patel, F. Vincenti.
Mayo Clinic, Phoenix; Novartis Pharmaceuticals Corporation, East Hanover; University of California, San Francisco.
The US92 study determined whether, in de novo renal transplant patients, concentration-controlled everolimus (EVR) with reduced dose tacrolimus (RTAC) is non-inferior to CellCept® (mycophenolate mofetil…
2016 American Transplant Congress
Validation of the Kidney Donor Risk Index (KDRI) in the Australian and New Zealand Kidney Transplant Population.
P. Clayton,^1,2,3 S. White,^1,4 S. McDonald,^1,2,3 S. Chadban.^1,4,5
¹Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, Royal Adelaide Hospital, Adelaide, SA, Australia; ²Central Northern Adelaide Renal and Transplantation Service, Royal Adelaide Hospital, Adelaide, SA, Australia; ³School of Medicine, University of Adelaide, Adelaide, SA, Australia; ⁴Sydney Medical School, University of Sydney, Sydney, NSW, Australia; ⁵Renal Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.
Purpose: The kidney donor risk index (KDRI), developed by the United States Scientific Registry of Transplant Recipients (SRTR), was designed to quantify donor kidney quality.…
2016 American Transplant Congress
Soluble ST2 and Cardiovascular (CV) Outcomes and Mortality in Kidney Transplant Candidates.
M. Keddis,¹ Z. El-Zoghby,² A. Gray,² J. Meeusen,² L. Donato,² F. Cosio,² D. Steidley.¹
¹Mayo Clinic, Phoenix, AZ; ²Mayo Clinic, Rochester, MN.
Introduction: Soluble ST2(sST2), involved in T-cell mediated inflammation and cardiac fibrosis, is a better predictor of cardiovascular events(CVE) in heart failure(HF) and is less affected…